University of Virginia
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Virginia sits in the top decile of US sponsors by registered trial count (#78 of 15,742 sponsors by registered trial count).
University of Virginia: 449 sponsored US clinical trials, 101 recruiting.
University of Virginia sponsors 449 registered US clinical trials on ClinicalTrials.gov, 101 of them currently recruiting, and 281 completed. 40 of these trials are in Phase 3-4 (later-stage) and 109 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 1 Diabetes Mellitus, with 9 trials.
Top-decile sponsor footprint
University of Virginia ranks in the top decile of sponsors by registered trial count (#78 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
281 of 317 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
449 total, page 3 of 9
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
NCT00929006
Perfusion Abnormalities in Hypertrophic Cardiomyopathy
NCT06599229
Feasibility of Delivering VergeRx at FQHCs
NCT06161675
iSIPsmarter: A Pilot RCT to Evaluate a Web-based Behavioral Intervention to Reduce Sugary Beverages Among Black Adults
NCT06184737
Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients
NCT05514847
Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies
NCT05370469
Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL
NCT03962465
Development of UP2UTobacco for High School Youth
NCT05396911
Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL
NCT03240211
The Use of Memantine for Prevention of Alzheimer's Disease
NCT05063851
Imaging Sodium and Lymphatics in Lymphedema
NCT05242900
The R-CITY Project: A Collaborative Intervention With Teachers and Youth
NCT05585918
Visualizing Vascular Mechanisms of Lipedema
NCT05464927
Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS
NCT04482894
Low Intensity Shockwave Therapy for Erectile Dysfunction
NCT04434352
Lymphocyte Depletion and Change in Lymphocyte Functionality
NCT04273893
Advanced Immunoclinical Phenotyping of Rejection in Lung Transplant
NCT03697395
Her2-BATS and Pembrolizumab in Metastatic Breast Cancer
NCT03272334
Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics
NCT03002389
BATs Treatment for Pancreatic Cancer, Phase Ib/II
NCT03269526
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
NCT01915615
VergeRx for Smokers Not Ready to Quit
NCT07693660
Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid
NCT07694492
The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)
NCT07298915
MCE Molecular Imaging for ICI Myocarditis
NCT07538544
A Pre-post Pilot of a Smartphone Intervention
NCT07665346
Evaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk Melanoma
NCT07653087
Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI
NCT05880355
Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study
NCT07146685
Validation of a Portable Ankle Arthrometer
NCT07163897
Inorganic Nitrate as a Treatment for ANOCA: NO-ANOCA
NCT06948201
Smartphone-based Utility of the Vestibulo-ocular Reflex
NCT06856746
InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy
NCT06411548
Cell-Surface Plectin in the Diagnosis of Cholangiocarcinoma from ERCP-directed Biliary Samples
NCT06651346
Investigating the Cholinergic Contribution to Gait Dysfunction in Parkinson's Disease
NCT06903910
Evaluating the Anticancer Learning Circle Lifestyle Program in Endometrial Cancer Survivors
NCT06550791
Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes
NCT06024928
Effects of Foot Rehabilitation And Minimalist Shoes on Pain, Strength, and Function in Adults With Plantar Fasciopathy
NCT06106958
Pharmacokinetics of Berkeley Life Oral Nitrate Supplementation
NCT06777108
Optical Measurements of the Skin Surface to Infer Distinctions in Myofascial Tissue Stiffness
NCT06390085
Integrated Predictive Monitoring for Sepsis and Necrotizing Enterocolitis
NCT07254559
The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.
NCT06111508
Neural-net Artificial Pancreas (NAP)
NCT05876273
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
NCT05786014
Low-Intensity Focused Ultrasound for Cocaine Use Disorder
NCT05857852
Exercise Preconditioning with Cancer Surgeries
NCT04923672
Fruit and Vegetable Intake in Preschoolers
NCT05730530
Hiatal Hernia and Pulmonary Involvement
NCT05716022
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
NCT05605301
mMe: Motivational Monitoring to Enhance Smoking Cessation Among Cancer Patients
NCT05370859
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 58 |
| Phase 2 | 51 |
| Phase 3 | 14 |
| Phase 4 | 26 |
Therapeutic Areas
What is open in the University of Virginia pipeline
101 recruiting of 449 indexed (22% open); 281 completed (63%).
Phase mix: 40 late (III/IV) vs 109 early (I/II) (early-phase heavy).
Top condition: Type 1 Diabetes Mellitus (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Virginia: open-pipeline peers nationwide
Peers matched on 449 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
University of Virginia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 449 trials (± recruiting share)
- Medical College of Wisconsin · 447 trials · 21% recruiting
- Alliance for Clinical Trials in Oncology · 446 trials · 7% recruiting
- Boston Children's Hospital · 462 trials · 24% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
Sponsors near 22% open enrollment (± trial volume)
- Ohio State University Comprehensive Cancer Center · 23% recruiting · 341 trials
- University of Delaware · 23% recruiting · 106 trials
- University of Oklahoma · 22% recruiting · 358 trials
- ALX Oncology · 22% recruiting · 9 trials
Related
What to do with this University of Virginia page
449 registered trials is a research-attention snapshot, not an endorsement of University of Virginia or any single study.
- 101 of University of Virginia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 1 Diabetes Mellitus is the condition University of Virginia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 1 Diabetes Mellitus trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Virginia pipeline card: 449 registered trials from official public datasets.Report a data error.